✦ LIBER ✦

CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone

✍ Scribed by D. John Betteridge

Book ID: 111194652
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 66 KB
Volume: 23
Category: Article
ISSN: 0767-3981
DOI: 10.1111/j.1472-8206.2009.00741.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pioglitazone lowers CV risk in diabetics

Pioglitazone lowers CV risk in diabetics with CKD

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Pioglitazone and oral cancer risk in pat

Pioglitazone and oral cancer risk in patients with type 2 diabetes

✍ Tseng, Chin-Hsiao 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Effects of pioglitazone on major adverse

Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10)

✍ Robert Wilcox; Stuart Kupfer; Erland Erdmann 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Pioglitazone and the risk of cardiovascu

Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin–angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20)

✍ Erland ERDMANN; Robert SPANHEIMER; Bernard CHARBONNEL; on behalf of the PROactiv 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB

Safety and Tolerability of Pioglitazone

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes

✍ Professor John Dormandy, Mondira Bhattacharya, Anne-Ruth van Troostenburg de Bru 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 289 KB

Rosiglitazone and pioglitazone increase

Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes

✍ R. E. Aubert; V. Herrera; W. Chen; S. M. Haffner; M. Pendergrass 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB